UNSPSC 41151710: Benzodiazepine test system

In this classification, a Benzodiazepine test system is a device intended to measure Benzodiazepine for clinical toxicology purposes. US FDA regulates Benzodiazepine test system under 21 CFR 862.3170 and under FDA product code JXM

UNSPSC 41151710 Benzodiazepine test system is a Commodity code that does not align with recent state and local procurement activity in the available opportunities block. The code nominally describes diagnostic test systems for benzodiazepine detection, but the recent opportunities posted under or near this code span laboratory analytical instruments, university research equipment, water testing reagents, crime lab systems, aquaculture monitoring gear, educational materials, and modular buildings—none of which involve benzodiazepine screening or drug testing as a primary application.

The mismatch is systematic. Recent opportunities from Mississippi State University, the University of Southern Mississippi, the City of Philadelphia, Brazoria County, Texas, the State of Oregon, Broward County, Florida, Gwinnett County, Georgia, and other jurisdictions show procurement of mass spectrometers (LC-QQQ systems), specialized rheometers and DMA equipment, motion-capture systems, nitrogen generators, photobioreactors, ultrafiltration gear, control systems, fire alarm components, and spectroscopy instruments—none of which function as benzodiazepine test systems or drug screening platforms. This code shows little relevant recent activity in state and local markets; the opportunities tagged to it do not reflect the code's nominal scope.